Financials Everest Organics Limited

Equities

EVERESTO6

INE334C01029

Pharmaceuticals

Market Closed - Bombay S.E. 03:30:56 01/07/2024 pm IST 5-day change 1st Jan Change
138.1 INR +0.25% Intraday chart for Everest Organics Limited +1.43% +9.04%

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 880 1,302 760 1,840 1,390 761.3
Enterprise Value (EV) 1 1,110 1,527 960.4 2,060 1,795 1,270
P/E ratio 34.1 x 17.3 x 6.98 x 13.4 x 122 x -414 x
Yield - 0.61% 1.05% 0.65% 0.29% -
Capitalization / Revenue 0.78 x 0.83 x 0.45 x 1.01 x 0.69 x 0.41 x
EV / Revenue 0.99 x 0.98 x 0.57 x 1.13 x 0.89 x 0.69 x
EV / EBITDA 14.9 x 8.37 x 4.22 x 8.81 x 22.2 x 70.8 x
EV / FCF -22.5 x -104 x 93.5 x -67.2 x -10.3 x -9.35 x
FCF Yield -4.45% -0.96% 1.07% -1.49% -9.72% -10.7%
Price to Book 4.71 x 5.01 x 2.22 x 3.95 x 2.97 x 1.65 x
Nbr of stocks (in thousands) 8,000 8,000 8,000 8,000 8,000 8,000
Reference price 2 110.0 162.8 95.00 230.0 173.8 95.16
Announcement Date 27/08/18 18/08/19 14/08/20 26/08/21 02/09/22 02/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 1,125 1,563 1,679 1,821 2,016 1,839
EBITDA 1 74.56 182.4 227.4 234 80.85 17.92
EBIT 1 47.8 154.1 195.3 200.3 42.88 -26.82
Operating Margin 4.25% 9.86% 11.63% 11% 2.13% -1.46%
Earnings before Tax (EBT) 1 23.64 123.3 140.9 172.7 17.39 0.899
Net income 1 17.14 75.09 109 137.1 11.44 -1.822
Net margin 1.52% 4.81% 6.49% 7.53% 0.57% -0.1%
EPS 2 3.230 9.390 13.62 17.14 1.430 -0.2300
Free Cash Flow 1 -49.37 -14.71 10.27 -30.65 -174.6 -135.8
FCF margin -4.39% -0.94% 0.61% -1.68% -8.66% -7.39%
FCF Conversion (EBITDA) - - 4.52% - - -
FCF Conversion (Net income) - - 9.43% - - -
Dividend per Share - 1.000 1.000 1.500 0.5000 -
Announcement Date 27/08/18 18/08/19 14/08/20 26/08/21 02/09/22 02/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 230 225 200 221 405 508
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 3.09 x 1.231 x 0.8816 x 0.9438 x 5.007 x 28.37 x
Free Cash Flow 1 -49.4 -14.7 10.3 -30.6 -175 -136
ROE (net income / shareholders' equity) 9.86% 33.6% 36.2% 34% 2.45% -0.39%
ROA (Net income/ Total Assets) 3.31% 9.55% 10.7% 9.79% 1.71% -0.88%
Assets 1 517.3 785.8 1,016 1,401 668.7 206.5
Book Value Per Share 2 23.40 32.50 42.80 58.20 58.50 57.80
Cash Flow per Share 2 0.4600 2.450 2.500 2.080 0.8100 1.040
Capex 1 34.6 72 71.9 68.5 172 135
Capex / Sales 3.08% 4.61% 4.28% 3.76% 8.51% 7.36%
Announcement Date 27/08/18 18/08/19 14/08/20 26/08/21 02/09/22 02/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. EVERESTO6 Stock
  4. Financials Everest Organics Limited